Author Correction: Presynaptic dopaminergic terminal imaging and non-motor symptoms assessment of Parkinson's disease: evidence for dopaminergic basis?

Qamar, M A; Sauerbier, A; Politis, M; Carr, H; Loehrer, P A; Chaudhuri, K Ray

Qamar, M A; Sauerbier, A; Politis, M; Carr, H; Loehrer, P A; Chaudhuri, K Ray.

Afiliação

Qamar MA; National Parkinson's Foundation International Center of Excellence, King's College London and King's College Hospital NHS Foundation Trust, London, UK. mubasher.qamar@doctors.org.uk.
Sauerbier A; National Parkinson's Foundation International Center of Excellence, King's College London and King's College Hospital NHS Foundation Trust, London, UK.
Politis M; Neurodegeneration Imaging Group, Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology and Neuroscience (IoPPN), King's College London, London, UK.
Carr H; National Parkinson's Foundation International Center of Excellence, King's College London and King's College Hospital NHS Foundation Trust, London, UK.
Loehrer PA; National Parkinson's Foundation International Center of Excellence, King's College London and King's College Hospital NHS Foundation Trust, London, UK.
Chaudhuri KR; Department of Neurology, University Hospital Cologne, Cologne, Germany.

NPJ Parkinsons Dis ; 9(1): 16, 2023 Feb 03.

Article em En | MEDLINE | ID: mdl-36737446

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies Idioma: En Revista: NPJ Parkinsons Dis Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google